4.5 Article

3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas

期刊

JOURNAL OF NEURO-ONCOLOGY
卷 153, 期 2, 页码 303-311

出版社

SPRINGER
DOI: 10.1007/s11060-021-03770-2

关键词

Glioma; Radiation oncology; Magnetic resonance imaging; Magnetic resonance spectroscopy; Astrocytoma; Choline

资金

  1. BRP [U01 EB028145]
  2. Winship American Cancer Society Institutional Research Grant Program

向作者/读者索取更多资源

The study aims to investigate the improvement of characterization and tissue sampling of low-to-intermediate grade gliomas using MRSI, and the results indicate that MRSI is predictive of areas of subsequent recurrence in these patients.
Purpose MRI is the standard imaging modality used for diagnosis, treatment planning, and post-treatment management of gliomas. Contrast-enhanced T1-weighted (CE-T1w) MRI is used to plan biopsy and radiation for grade IV gliomas but is less effective for grade II and III gliomas (i.e., low-to-intermediate grade gliomas) which may have minimal or no enhancement. Magnetic resonance spectroscopic imaging (MRSI) is an advanced MRI technique that has been shown, to improve diagnostic yield of biopsy and target delineation for grade IV glioma. The purpose of this study is to determine if MRSI can improve characterization and tissue sampling of low-to-intermediate grade gliomas. Methods Prospective grade II and grade III glioma patients were enrolled to undergo whole brain high-resolution MRSI prior to tissue sampling. Choline/N-acetyl-aspartate (Cho/NAA) maps were overlaid on anatomic imaging and imported into stereotactic biopsy software. Patients were treated with standard-of-care surgery and radiation. Volumes of spectroscopically abnormal tissue were generated and compared with anatomic imaging and areas of enhancing recurrence on follow-up imaging. Results Ten patients had pathologic diagnosis of grade II (n = 4) or grade III (n = 6) with a median follow-up of 27.3 months. Five patients had recurrence, and regions of recurrence were found to overlap with metabolically abnormal regions on MRSI at the time of diagnosis. Conclusion MRSI in low-to-intermediate grade glioma patients is predictive of areas of subsequent recurrence. Larger studies are needed to determine if MRSI can be used to guide surgical and radiation treatment planning in these patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据